pharmaceutical
FlyPharma Conference Europe concludes its fourth successful year in Brussels
June 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical
The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …
Milan’s decision to appeal the EMA HQ relocation explained
June 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Milan, biotech, drugs, pharma, pharmaceutical
The decision to award the EMA headquarters to Amsterdam was a contentious one, not least because the vote had to …
Amgen/Novartis migraine med gets CHMP nod
June 4, 2018Sales and Marketing Aimovig, Amgen, Novartis, biotech, drugs, pharma, pharmaceutical
Amgen and Novartis have announced that their newly FDA-approved treatment for migraines has received a recommendation from the CHMP, generally …
Keytruda offers significant hope in subset of prostate cancer
June 4, 2018Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, prostate cancer
Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at …
Celgene bring in new CFO to steady the ship
June 4, 2018Medical Communications, Sales and Marketing Celgene, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
Bayer eyes R&D cuts, as Monsanto deal raises question of focus
June 1, 2018Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical
When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …
Roche resigns itself to failure on SMA drug
June 1, 2018Medical Communications Roche, biotech, drugs, pharma, pharmaceutical, spinal muscular atrophy
Roche has announced that it will no longer seek to develop its treatment for spinal muscular atrophy (SMA), olesoxime, after …
Novartis’ US Oncology head makes leap to become biotech CEO
June 1, 2018Medical Communications Novartis, axcella, biotech, drugs, pharma, pharmaceutical
The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
Staff shortfall leads to massive deficit for NHS
May 31, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The headline figure is that the NHS budget deficit for the year 2017/2018 came in at £960 million, close to …
Allergan aims to appease investors with non-core units sell off
May 31, 2018Medical Communications Allergan, biotech, drugs, pharma, pharmaceutical
Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …
FDA approval for TherapeuticsMD, one year after initial rejection
May 30, 2018Sales and Marketing FDA, TherapeuticsMD, biotech, drugs, pharma, pharmaceutical
TherapeuticsMD has succeeded in changing the FDA’s mind on its Imvexxy product, after an initial rejection in May of last …
AZ’s hopes for Fasenra in COPD suffer terminal blow
May 30, 2018Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
It looked unlikely that Fasenra would achieve success in the chronic obstructive pulmonary disease (COPD) area, after it suffered in …
NHS England uses £10m fund to retain GPs
May 30, 2018Medical Communications, Research and Development GP, NHS, UK government, biotech, drugs, pharma, pharmaceutical
On the day that news broke, through Pulse, that over a million patients have had to move GP surgery in …
Head of Sandoz UK becomes BGMA chair
May 30, 2018Manufacturing and Production, Research and Development British Generic Manufacturers Association, biotech, drugs, pharma, pharmaceutical
Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …
BioMarin receives FDA nod for its would-be blockbuster
May 25, 2018Medical Communications, Sales and Marketing BioMarin, biotech, drugs, pharma, pharmaceutical
BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
